AMRN
Amarin Corporation PLC
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 14.36
Buy <=wait / entry
USD 10.50
Trim >=take some off
USD 15.50
Thesis breakA dilutive equity raise executed at a material discount to the prevailing share ...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 25% | 100 / 100 | 25.0 |
| Base case | 50% | 62 / 100 | 31.0 |
| Bear case | 25% | 10 / 100 | 2.5 |
| Weighted conviction | 59 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- European-focused exclusive licensing and supply agreement with Recordati S.p.A. driving higher European product revenue
- Q1 2026 total revenue increase led by international sales with positive cash flow and reiterated full-year positive cash flow expectation
- Updated industry guidelines and global medical society endorsements supporting icosapent ethyl use